Simplex Trading’s Cidara Therapeutics CDTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-5,230
| Closed | -$1.16M | – | 9142 |
|
|
2025
Q4 | $1.16M | Sell |
5,230
-7,897
| -60% | -$1.28M | ﹤0.01% | 2493 |
|
|
2025
Q3 | $1.26M | Sell |
13,127
-54,903
| -81% | -$3.5M | ﹤0.01% | 2813 |
|
|
2025
Q2 | $3.31M | Buy |
+68,030
| New | +$1.63M | ﹤0.01% | 1685 |
|
|
2024
Q2 | – | Sell |
-26
| Closed | – | – | 8861 |
|
|
2024
Q1 | $0 | Buy |
+26
| New | +$373 | ﹤0.01% | 8906 |
|
|
2023
Q2 | – | Sell |
-978
| Closed | -$23K | – | 9040 |
|
|
2023
Q1 | $24K | Buy |
+978
| New | +$27.8K | ﹤0.01% | 6710 |
|
|
2022
Q2 | – | Sell |
-32
| Closed | – | – | 10037 |
|
|
2022
Q1 | $0 | Sell |
32
-120
| -79% | -$2.04K | ﹤0.01% | 10460 |
|
|
2021
Q4 | $3K | Buy |
+152
| New | +$4.73K | ﹤0.01% | 9797 |
|
|
2021
Q2 | – | Sell |
-24
| Closed | -$1.01K | – | 10076 |
|
|
2021
Q1 | $1K | Buy |
+24
| New | +$1.19K | ﹤0.01% | 8535 |
|
|
2020
Q2 | – | Sell |
-94
| Closed | -$6.09K | – | 7657 |
|
|
2020
Q1 | $4K | Buy |
+94
| New | +$5.63K | ﹤0.01% | 6931 |
|
|
2019
Q4 | – | Sell |
-13
| Closed | -$595 | – | 7336 |
|
|
2019
Q3 | $0 | Buy |
+13
| New | +$437 | ﹤0.01% | 7278 |
|
|
2018
Q2 | – | Sell |
-161
| Closed | -$12K | – | 7385 |
|
|
2018
Q1 | $12K | Buy |
+161
| New | +$22K | ﹤0.01% | 3855 |
|
Simplex Trading's CDTX Position: Q1 2026 in Review
Simplex Trading sold out of Cidara Therapeutics (CDTX) in Q1 2026, closing a stake of 5,230 shares — an estimated $1.16M sold.
Simplex Trading first reported a position in CDTX in Q1 2018 and held it in 11 quarters. The position peaked at $3.31M in Q2 2025. 0 funds tracked by Wall St. Rank hold CDTX as of Q1 2026.
- Simplex Trading reported no remaining Cidara Therapeutics position as of Q1 2026 after selling out during the quarter.
- Simplex Trading sold 5,230 Cidara Therapeutics shares in Q1 2026, an estimated $1.16M.
- Simplex Trading first reported a position in Cidara Therapeutics in Q1 2018 and held it in 11 quarters.
- Simplex Trading's Cidara Therapeutics position peaked at $3.31M in Q2 2025.
- 0 funds tracked by Wall St. Rank held Cidara Therapeutics as of Q1 2026.
Based on Simplex Trading's 13F filing for Q1 2026, filed 14 May 2026.